Jim Cramer has Celgene Corporation (NASDAQ:CELG), Facebook Inc (NASDAQ:FB), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) in his recent favorite stock list. He has mentioned each of these stocks at least four times during the last 30 days.
Celgene Corporation (NASDAQ:CELG) has been Cramer’s favorite for past several weeks and while talking about biotech stocks, Cramer said that his “four horsemen” including Celgene in biotech continue to remain terrific investments. He has mentioned this stock at least six times in the last 30 days and while discussing the Lighting Round of Mad Money show, Cramer said, “If you bought it at $68, sell some and let the rest run. It is a monster!” Earlier last month, Cramer predicted that the stock is not done going higher and considered it over other biotech stocks.
Cramer has mentioned Facebook Inc (NASDAQ:FB) five times in the last 30 days and after the drop in Facebook post its quarterly financial results last month, Cramer advised investors not to worry about the stock and the spending plans of the social media. Earlier last week, Cramer was bullish over the outlook of Facebook Inc (NASDAQ:FB) and added that investors might not be a fan of the recent quarterly results of the company but he still prefers the stock in longer run. According to Cramer, the company would generate revenue amid its five-year spending plan.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is another biotech stock in Cramer’s list and he even called it among the “four horsemen” along with Celgene Corporation (NASDAQ:CELG). Cramer mentioned Regeneron Pharmaceuticals Inc (NASDAQ:REGN) in his Mad Money stock list and while talking about Pfizer Inc. (NYSE:PFE), Cramer said, “I’d go with Isis Pharmaceuticals (ISIS) or Celgene (CELG) or Regeneron Pharmaceuticals Inc (NASDAQ:REGN).” Cramer mentioned his preference for both of these biotech stocks multiple times in the last 30 days.
This article has been written by Prakash Pandey.